SGHT — Sight Sciences Share News
0.000.00%
Last trade - 00:00- $287.28m
- $242.86m
- $77.36m
Sight Sciences Inc reports results for the quarter ended December 31 - Earnings Summary
Sight Sciences Inc expected to post a loss of 20 cents a share - Earnings Preview
Sight Sciences Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Sight Sciences Q3 Revenue USD 20.2 Million Vs. IBES Estimate USD 20.4 Million
Sight Sciences Inc expected to post a loss of 21 cents a share - Earnings Preview
Brief: Sight Sciences Q2 Revenue USD 21.4 Million Vs. IBES Estimate USD 21.3 Million
Sight Sciences Inc reports results for the quarter ended in March - Earnings Summary
Brief: Sight Sciences Q1 Revenue USD 19.3 Million Vs. IBES Estimate USD 18.4 Million
Sight Sciences Inc expected to post a loss of 28 cents a share - Earnings Preview
Brief: Sight Sciences Announces $34 Mln Patent Infringement Verdict Against Alcon And Hydrus Microstent
Sight Sciences Inc reports results for the quarter ended in December - Earnings Summary
Brief: Sight Sciences Reports Fourth Quarter And Full Year 2023 Financial Results And Initiates Full Year 2024 Financial Guidance
Brief: Sight Sciences Q4 Revenue USD 18.8 Million Vs. IBES Estimate USD 18.9 Million
Sight Sciences Inc expected to post a loss of 32 cents a share - Earnings Preview
Brief: Sight Sciences Announces The Closing Of Up To $65 mln Senior Secured Credit Facility With Hercules Capital
Brief: Sight Sciences Says 5 Medicare Administrative Contractors Update Future Effective Local Coverage Determinations On Micro-Invasive Glaucoma Surgery
Brief: Sight Sciences Q3 Revenue USD 20 Million Vs. IBES Estimate USD 21.6 Million
Brief: Sight Sciences Says Evaluating Guidance For FY 2023 Due To Uncertain Impact Of Reimbursement Coverage For Its Surgical Glaucoma Segment
Brief: Sight Sciences Inc Intends To Reduce Its Headcount By 25 Employees, Or About 10%